Crossmark

Predicting Recurrence After Radical Surgery for High-Risk Renal Cell Carcinoma: Development and Internal Validation of the “TOWARDS” Score

Published Online: 2024-01-29

Published Print: 2024-05

Authors

Ishiyama, Yudai

Omae, Kenji

Kondo, Tsunenori

Yoshida, Kazuhiko

Iizuka, Junpei

Takagi, Toshio
License Information

Text and Data Mining valid from 2024-01-29

Version of Record valid from 2024-01-29
More Information

Article History

Received: 29 September 2023

Accepted: 10 January 2024

First Online: 29 January 2024

Disclosures

: Kenji Omae received honoraria from Pfizer and Ono Pharmaceutical. Tsunenori Kondo received honoraria from Pfizer, Takeda, MSD, and Ono Pharmaceutical. Toshio Takagi received honoraria from Ono Pharmaceutical. The remaining authors have no conflicts of interest.

Document is current